TechConnect #techconnect keeps getting better every year! Anaheim was a great location, with a good mix of entrepreneurs and investors! Looking forward to the next one in Boston in May 2019. I chaired a very engaging panel of experts who elaborated on the biggest problem facing the industrial production of uniform nanoparticles. I showcased Notre Dame’s expanding Nanoparticles synthesis capabilities. Prof. Leevy talked about the challenges of being an entrepreneur in an academic setting and how Notre Dame’s IDEA center #IDEAcenter is making that process easier. Dr. Andrew Wang, the co-founder of Ocean Nanotech and Alpha BioBeads, talked about the current challenges of commercially synthesizing nanomaterials. Dr. Wei Wang or Saudi Aramco Research Center further expounded on the need to translate nanotechnology from a working concept in the lab to a fully working field instrument in challenging environments such as offshore oil wells. Finally, Dr. Parlak who founded ‘Qatch diagnostics technologies’ talked about the joys, pains and unique satisfaction of running a startup.
May 14
TechConnect 2018 an SBIR/STTR Haven
Categories:
Berthiaume Institute for Precision Health, Biomedical Imaging, Conference abstracts, SBIR/STTR
by Prakash
This post has no tag
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025 April 3, 2025Notice NOT-OD-25-085 from the NIH Guide for Grants and Contracts
- NIH Operates Under a Continuing Resolution April 3, 2025Notice NOT-OD-25-084 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PAR-23-220 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) April 3, 2025Notice NOT-OD-25-073 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PAR-23-219 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) April 3, 2025Notice NOT-OD-25-072 from the NIH Guide for Grants and Contracts
- Implementation Update: Enhancing Security Measures for NIH Controlled-Access Data April 1, 2025Notice NOT-OD-25-083 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) April 1, 2025Notice NOT-OD-25-078 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) April 1, 2025Notice NOT-OD-25-077 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) April 1, 2025Notice NOT-OD-25-076 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) April 1, 2025Notice NOT-OD-25-075 from the NIH Guide for Grants and Contracts
Recent Comments